Table 5

Adjusted ORs and 95% CIs for congenital urogenital anomalies by tertiles of internal THM exposure during the first trimester of pregnancy

THM internal dose tertile limits (µg/d)nFirst month OR* (95% CI)nSecond month OR* (95% CI)nThird month OR* (95% CI)nFirst trimester OR* (95% CI)
TTHM
 0.031–0.04051415141
 0.040–0.35681.54 (0.50 to 4.77)102.46 (0.77 to 7.93)81.52 (0.49 to 4.71)92.19 (0.67 to 7.18)
 0.356–2.448101.95 (0.66 to 5.76)92.32 (0.71 to 7.62)102.01 (0.68 to 5.96)102.49 (0.77 to 8.03)
 p†0.1760.1740.1750.115
 Continuous (1µg/d)1.92 (0.69 to 5.33)1.99 (0.72 to 5.49)2.02 (0.74 to 5.50)2.00 (0.72 to 5.56)
Chloroform
 0.001–0.02641414141
 0.026–0.288102.31 (0.72 to 7.43)112.45 (0.77 to 7.76)100.44 (0.13 to 1.44)92.21 (0.67 to 7.23)
 0.288–2.10992.20 (0.67 to 7.22)82.02 (0.60 to 6.76)91.01 (0.41 to 2.53)102.50 (0.78 to 8.06)
 p†0.1800.2730.1740.118
 Continuous (1µg/d)2.10 (0.65 to 6.74)2.21 (0.69 to 7.08)2.26 (0.71 to 7.20)2.22 (0.69 to 7.17)
BDCM
 0.000–0.01341616141
 0.013–0.051102.40 (0.75 to 7.73)60.90 (0.29 to 2.83)60.91 (0.29 to 2.86)71.65 (0.48 to 5.67)
 0.051–0.43692.27 (0.69 to 7.43)111.81 (0.66 to 4.96)111.85 (0.68 to 5.07)122.87 (0.92 to 8.99)
 p†0.1650.1650.1580.039
 Continuous (0.1µg/d)1.55 (0.70 to 3.40)1.56 (0.74 to 3.29)1.55 (0.76 to 3.20) 1.57 (0.74 to 3.37)
DBCM
 0.000–0.00271716161
 0.002–0.00670.89 (0.31 to 2.58)81.08 (0.39 to 3.00)91.42 (0.50 to 4.02)60.92 (0.29 to 2.87)
 0.006–0.09391.17 (0.43 to 3.16)81.06 (0.38 to 2.96)81.22 (0.42 to 3.56)111.79 (0.65 to 4.90)
 p†0.7000.8900.6700.210
 Continuous (0.01µg/d)1.17 (0.78 to 1.77)1.17 (0.80 to 1.71)1.17 (0.82 to 1.66)1.17 (0.80 to 1.72)
  • *Adjusted for: age, body mass index, chronic disease, previous premature birth and infant sex.

  • †χ2 for linear trend.

  • BDCM, bromodichloromethane; DBCM, dibromochloromethane; THM, trihalomethane; TTHM, total trihalomethane.